clinical trial · NCT05689164
A Study to Understand the Long-term Safety and Effects of an Experimental Gene Therapy for Duchenne Muscular Dystrophy.
Duchenne Muscular Dystrophyfordadistrogene movaparvovec
brief summary
The purpose of this study is to understand the safety and effects of an experimental gene therapy called fordadistrogene movaparvovec. We are seeking participants from previous Pfizer interventional studies. We will follow participants' experience in this study for 10 years after the end of their previous study. Participants will have 1 annual onsite visit and a few annual remote visits. The exact number of remote visits will be decided by their study doctor.
started
Mar 13, 2023
primary completion
Sep 24, 2025
completion
Sep 24, 2025
last updated
Nov 12, 2026
official title
Long-term Follow-up Safety and Efficacy Study in Participants With Duchenne Muscular Dystrophy Who Have Received Fordadistrogene Movaparvovec in a Preceding Clinical Study
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol